Association of the human leucocyte antigen region with susceptibility to Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 8, 2010, Pages 890-891

  Saiki, Misuzu ^a   Baker, Amie ^b   Williams Gray, Caroline H ^a   Foltynie, Thomas ^e   Goodman, Reyna S ^c   Taylor, Craig J ^c   Compston, D Alastair S ^b   Barker, Roger A ^a   Sawcer, Stephen J ^b   Goris, An ^b,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DRB1 ANTIGEN; HLA-DQB1 ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; ALLELE; COHORT ANALYSIS; DISEASE PREDISPOSITION; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; HISTOCOMPATIBILITY TEST; MIDDLE AGED; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; GENES, MHC CLASS II; GREAT BRITAIN; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 77955759020     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.162883     Document Type: Article

References (19)

1. Monahan AJ, Warren M, Carvey PM. Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis. Cell Transplant 2008;17:363-72. (Pubitemid 351717339)
2. Gerhard A, Pavese N, Hotton G, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 2006;21:404-12.
3. Orr CF, Rowe DB, Mizuno Y, et al. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 2005;128:2665-74. (Pubitemid 41552950)
4. Miklossy J, Qing H, Guo JP, et al. Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation. Acta Neuropat hol (Berl) 2007;114:243-54.
5. Marttila RJ, Rinne UK, Tiilikainen A. Histocompatibility types in Parkinson's disease. J Neurol Sci 1981;51:217-21.
6. Leheny WA, Davidson DL, deVane P, et al. HLA antigens in Parkinson's disease. Tissue Antigens 1983;21:260-1.
7. Reed E, Lewison A, Mayeaux R, et al. HLA antigens in Parkinson's disease. Tissue Antigens 1983;21:161-3.
8. Lampe JB, Gossrau G, Herting B, et al. HLA typing and Parkinson's disease. Eur Neurol 2003;50:64-8.
9. Kruger R, Hardt C, Tschentscher F, et al. Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm 2000;107:553-62.
10. Nishimura M, Mizuta I, Mizuta E, et al. Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease. Neurosci Lett 2001;311:1-4.
11. Ross OA, O'Neill C, Rea IM, et al. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish. Hum Immunol 2004;65:340-6.
12. Wu YR, Feng IH, Lyu RK, et al. Tumor necrosis factor-alpha promoter polymorphism is associated with the risk of Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2007;144:300-4.
13. Mizuta I, Satake W, Nakabayashi Y, et al. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Mol Genet 2006;15:1151-8.
14. Wahner AD, Sinsheimer JS, Bronstein JM, et al. Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Arch Neurol 2007;64:836-40.
15. Bialecka M, Klodowska-Duda G, Kurzawski M, et al. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients. Parkinsonism Relat Disord 2008;14:636-40.
16. Yeo TW, De Jager PL, Gregory SG, et al. A second MHC susceptibility locus for multiple sclerosis. Ann Neurol 2006;61:228-36.
17. Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
18. Fung HC, Scholz S, Matarin M, et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2006;5:911-16.
19. Allcock RJ, Windsor L, Gut IG, et al. High-Density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging. Hum Mutat 2004;24:517-25.